CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2026)

CRISPR Therapeutics AG has disclosed Asset Utilization Ratio across 11 years of filings, most recently posting 0.0 for Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.0, down 90.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0 (down 90.38% YoY), and the FY2025 annual result was 0.0, down 90.67% from the prior year.
• Asset Utilization Ratio came in at 0.0 for Q1 2026 at CRISPR Therapeutics AG, up from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.34 in Q1 2022 to a low of 0.0 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.02 (2025), against an average of 0.06.
• Peak annual rise in Asset Utilization Ratio reached 58644.33% in 2022, while the deepest fall reached 99.84% in 2022.
• CRISPR Therapeutics AG's Asset Utilization Ratio stood at 0.0 in 2022, then jumped by 32895.55% to 0.17 in 2023, then sank by 90.35% to 0.02 in 2024, then slumped by 90.62% to 0.0 in 2025, then advanced by 5.64% to 0.0 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.